UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway

PloS one, 2014-05, Vol.9 (5), p.e97094-e97094

2014

Link zum Volltext

Verfügbarkeit prüfen

Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes

Pharmaceuticals, 2013-11, Vol.6 (11), p.1361-1380

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting c-MYC in Platinum-Resistant Ovarian Cancer

Molecular cancer therapeutics, 2015-10, Vol.14 (10), p.2260-2269

2015

Link zum Volltext

Verfügbarkeit prüfen

Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells

International journal of molecular sciences, 2022-11, Vol.23 (23), p.14742

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells

Oncotarget, 2016-06, Vol.7 (24), p.36321-36337

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

Frontiers in medical technology, 2021-08, Vol.3, p.678593-678593

2021

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma

Frontiers in oncology, 2023-09, Vol.13, p.1249649-1249649

2023

Link zum Volltext

Verfügbarkeit prüfen

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells

International journal of molecular sciences, 2022-01, Vol.23 (1), p.535

2022

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Clinical cancer research, 2009-06, Vol.15 (11), p.3770-3780

2009

Link zum Volltext

Verfügbarkeit prüfen

Role of RNA Binding Protein with Multiple Splicing (RBPMS) Variants in Cell Proliferation, Invasion and Angiogenesis in Ovarian Cancer

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

A Fresh Look at the Potential of Cyclodextrins for Improving the Delivery of siRNA Encapsulated in Liposome Nanocarriers

ACS omega, 2022-02, Vol.7 (4), p.3731-3737

2022

Link zum Volltext

Verfügbarkeit prüfen

Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer

International journal of molecular sciences, 2020-06, Vol.21 (12), p.4365

2020

Link zum Volltext

Verfügbarkeit prüfen

Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles

Cancer research (Chicago, Ill.), 2010-05, Vol.70 (9), p.3687-3696

2010

Link zum Volltext

Verfügbarkeit prüfen

3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer

Journal of clinical and translational science, 2019-03, Vol.3 (s1), p.112-112

2019

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value

American journal of cancer research, 2015-01, Vol.5 (1), p.201-218

2015

Link zum Volltext

Verfügbarkeit prüfen

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis

The Journal of clinical investigation, 2010-05, Vol.120 (5), p.1515-1523

2010

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer

Clinical cancer research, 2015-01, Vol.21 (2), p.448-459

2015

Link zum Volltext

Verfügbarkeit prüfen

RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials

Life sciences (1973), 2017-11, Vol.188, p.26-36

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA

Cancer research (Chicago, Ill.), 2008-11, Vol.68 (21), p.9078-9086

2008

Link zum Volltext

Verfügbarkeit prüfen

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma

International journal of nanomedicine, 2020-01, Vol.15, p.2809-2828

2020

Link zum Volltext

Verfügbarkeit prüfen

Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Clinical cancer research, 2021-08, Vol.27 (15), p.4454-4454

2021

Link zum Volltext

Verfügbarkeit prüfen

c-MYC and Epithelial Ovarian Cancer

Frontiers in oncology, 2021-02, Vol.11, p.601512-601512

2021

Link zum Volltext

Verfügbarkeit prüfen

Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer

Clinical cancer research, 2011-06, Vol.17 (11), p.3716-3726

2011

Link zum Volltext

Verfügbarkeit prüfen

96 Unlocking the Potential of Simalikalactone D as an Anticancer Agent in Ethnically Diverse Breast Cancer Populations

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.26-26

2024

Link zum Volltext

Verfügbarkeit prüfen

ATP11B mediates platinum resistance in ovarian cancer

The Journal of clinical investigation, 2021-04, Vol.131 (7)

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(103)
Buchkapitel
(1)

Sprache

Englisch
(104)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(49)
Humans
(37)
Oncology
(34)
Animals
(27)
Cell Line, Tumor
(27)
Female
(26)
Mice
(21)
Ovarian Cancer
(20)
Ovarian Neoplasms - Pathology
(17)
Tumors
(17)
Ovarian Neoplasms - Genetics
(15)
Mice, Nude
(14)
Cancer
(13)
Antineoplastic Agents - Pharmacology
(12)
Apoptosis
(12)
Cell Proliferation
(12)
Proteins
(11)
Chemotherapy
(10)
Gene Expression
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway

Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes

Targeting c-MYC in Platinum-Resistant Ovarian Cancer

Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells

Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells

Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Role of RNA Binding Protein with Multiple Splicing (RBPMS) Variants in Cell Proliferation, Invasion and Angiogenesis in Ovarian Cancer

A Fresh Look at the Potential of Cyclodextrins for Improving the Delivery of siRNA Encapsulated in Liposome Nanocarriers

Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer

Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles

3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer

MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis

Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer

RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma

Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma

c-MYC and Epithelial Ovarian Cancer

Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer

96 Unlocking the Potential of Simalikalactone D as an Anticancer Agent in Ethnically Diverse Breast Cancer Populations

ATP11B mediates platinum resistance in ovarian cancer

Suchergebnisse filtern